208 related articles for article (PubMed ID: 12381909)
1. c-Met expression in gastric cancer with liver metastasis.
Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
3. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.
Huang TJ; Wang JY; Lin SR; Lian ST; Hsieh JS
Acta Oncol; 2001; 40(5):638-43. PubMed ID: 11669338
[TBL] [Abstract][Full Text] [Related]
5. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
7. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
8. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
Zhao ZS; Ru GQ; Ma J
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
[TBL] [Abstract][Full Text] [Related]
9. [Increased expression of the c-Met receptor mRNA in gastric cancer].
Amemiya H; Peña A; Chiurillo M; Moscoso J; Useche A; Baffi R
Invest Clin; 2013 Sep; 54(3):284-98. PubMed ID: 24354242
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer.
Yokobori T; Mimori K; Ishii H; Iwatsuki M; Tanaka F; Kamohara Y; Ieta K; Kita Y; Doki Y; Kuwano H; Mori M
Ann Surg Oncol; 2010 Oct; 17(10):2601-7. PubMed ID: 20422456
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer.
Liu N; Zhang LH; Du H; Hu Y; Zhang GG; Wang XH; Li JY; Ji JF
Ann Surg Oncol; 2010 Oct; 17(10):2628-39. PubMed ID: 20383661
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
14. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
[TBL] [Abstract][Full Text] [Related]
16. Expression of the c-Met proto-oncogene and Integrin α5β1 in human gastric cardia adenocarcinoma.
Chi F; Fu D; Zhang X; Lv Z; Wang Z
Biosci Biotechnol Biochem; 2012; 76(8):1471-6. PubMed ID: 22976495
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
18. [Association of expression of HGF and its receptor c-Met to primary colorectal cancers with synchronous liver metastasis].
Sun Y; Li Z; Xu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):598-601. PubMed ID: 24953371
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.
Noguchi E; Saito N; Kobayashi M; Kameoka S
Mol Med Rep; 2015 May; 11(5):3423-31. PubMed ID: 25592281
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]